Skip to main content
If you continue browsing this website, you agree to our policies:
  • Politique de confidentialité
Continue
x
eCampus
  • Home
  • Outils
    Portfolio Mahara Wooclap
  • Tutoriels
    bientôt disponible !
  • More
English ‎(en)‎
English ‎(en)‎ Español - Internacional ‎(es)‎ Français ‎(fr)‎
You are currently using guest access
Log in
eCampus
Home Outils Collapse Expand
Portfolio Mahara Wooclap
Tutoriels Collapse Expand
bientôt disponible !
Expand all Collapse all
  1. Dashboard
  2. UPSAY_2024_920_UE_A5UE75A
  3. UE75 ED3 : Documents et questions
  4. UE 75 ED3 Ravalizumab Vu et al NEJM Evidence 2022

UE 75 ED3 Ravalizumab Vu et al NEJM Evidence 2022

Completion requirements

PDF

Click UE 75_ED3_Ravalizumab_Vu et al NEJM Evidence 2022.pdf link to view the file.
◄ UE 75 ED3 Ravalizumab immunotargets and therapy 2020
UE 75 ED3 Ravalizumab Tokuyasu et al ACTN 2024 ►
You are currently using guest access (Log in)
Policies
Get the mobile app
Powered by Moodle

eCampus

Université Paris-Saclay 7
  • UPSaclay
  • UEVE
  • UVSQ
  • Centrale Supélec
  • École Normale Supérieure
  • Institut d'Optique
  • AgroParisTech
Institut Polytechnique de Paris 3
  • ENSTA
  • Télécom Paris

European University Alliance for Global Health (EUGLOH)
  •  


Nouveautés